1. Real-world Clinical Outcomes Among Patients With Type 2 Diabetes Receiving Canagliflozin at a Specialty Diabetes Clinic: Subgroup Analysis by Baseline HbA1c and Age 
June Felice Johnson, PharmD, Rahul Parsa, PhD, Robert A. Bailey, MD 
Clinical Therapeutics 
Volume 39, Issue 6, Pages (June 2017)
DOI: /j.clinthera
Copyright © 2017 Elsevier HS Journals, Inc. Terms and Conditions

2. Figure 1
Mean hemoglobin A1c (HbA1c) (A), body weight (B), systolic blood pressure (BP) (C), and diastolic BP (D) over time, by baseline HbA1c, in patients with data from baseline and any follow-up office visit (OV). Paired t tests were performed for determining the significance of changes from baseline to each OV; statistical significance was defined as P < To convert pounds to kilograms, multiply by 0.45.
Clinical Therapeutics  , DOI: ( /j.clinthera )
Copyright © 2017 Elsevier HS Journals, Inc. Terms and Conditions

3. Figure 2
Mean hemoglobin A1c (HbA1c) (A), body weight (B), systolic blood pressure (BP) (C), and diastolic BP (D) over time, by age, in patients with data from baseline and any follow-up office visit (OV). Paired t tests were performed for determining the significance of changes from baseline to each OV; statistical significance was defined as P < To convert pounds to kilograms, multiply by 0.45.
Clinical Therapeutics  , DOI: ( /j.clinthera )
Copyright © 2017 Elsevier HS Journals, Inc. Terms and Conditions